Eiron R. Cudaback, Ph.D. - Publications

University of Washington, Seattle, Seattle, WA 
Cannabinoid signaling and neuroinflammation

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Miller JA, Guillozet-Bongaarts A, Gibbons LE, Postupna N, Renz A, Beller AE, Sunkin SM, Ng L, Rose SE, Smith KA, Szafer A, Barber C, Bertagnolli D, Bickley K, Brouner K, ... ... Cudaback E, et al. Neuropathological and transcriptomic characteristics of the aged brain. Elife. 6. PMID 29120328 DOI: 10.7554/Elife.31126  0.305
2015 Melief EJ, Cudaback E, Jorstad NL, Sherfield E, Postupna N, Wilson A, Darvas M, Montine KS, Keene CD, Montine TJ. Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's disease. Journal of Neuroscience Research. 93: 1413-22. PMID 25824456 DOI: 10.1002/Jnr.23592  0.315
2015 Cudaback E, Yang Y, Montine TJ, Keene CD. APOE genotype-dependent modulation of astrocyte chemokine CCL3 production. Glia. 63: 51-65. PMID 25092803 DOI: 10.1002/Glia.22732  0.385
2014 Yang Y, Aloi MS, Cudaback E, Josephsen SR, Rice SJ, Jorstad NL, Keene CD, Montine TJ. Wild-type bone marrow transplant partially reverses neuroinflammation in progranulin-deficient mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 94: 1224-36. PMID 25199051 DOI: 10.1038/Labinvest.2014.113  0.353
2014 Sexton M, Cudaback E, Abdullah RA, Finnell J, Mischley LK, Rozga M, Lichtman AH, Stella N. Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. Inflammopharmacology. 22: 295-303. PMID 25135301 DOI: 10.1007/S10787-014-0214-Z  0.504
2014 Cudaback E, Jorstad NL, Yang Y, Montine TJ, Keene CD. Therapeutic implications of the prostaglandin pathway in Alzheimer's disease. Biochemical Pharmacology. 88: 565-72. PMID 24434190 DOI: 10.1016/J.Bcp.2013.12.014  0.351
2013 Yu CE, Cudaback E, Foraker J, Thomson Z, Leong L, Lutz F, Gill JA, Saxton A, Kraemer B, Navas P, Keene CD, Montine T, Bekris LM. Epigenetic signature and enhancer activity of the human APOE gene. Human Molecular Genetics. 22: 5036-47. PMID 23892237 DOI: 10.1093/Hmg/Ddt354  0.306
2013 Yang Y, Cudaback E, Jorstad NL, Hemingway JF, Hagan CE, Melief EJ, Li X, Yoo T, Khademi SB, Montine KS, Montine TJ, Keene CD. APOE3, but not APOE4, bone marrow transplantation mitigates behavioral and pathological changes in a mouse model of Alzheimer disease. The American Journal of Pathology. 183: 905-17. PMID 23831297 DOI: 10.1016/J.Ajpath.2013.05.009  0.389
2012 Cudaback E, Li X, Yang Y, Yoo T, Montine KS, Craft S, Montine TJ, Keene CD. Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation. Journal of Neuroinflammation. 9: 192. PMID 22883744 DOI: 10.1186/1742-2094-9-192  0.381
2012 Li X, Cudaback E, Breyer RM, Montine KS, Keene CD, Montine TJ. Eicosanoid receptor subtype-mediated opposing regulation of TLR-stimulated expression of astrocyte glial-derived neurotrophic factor. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 3075-83. PMID 22499581 DOI: 10.1096/Fj.11-200279  0.473
2011 Keene CD, Cudaback E, Li X, Montine KS, Montine TJ. Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease. Current Opinion in Neurobiology. 21: 920-8. PMID 21907569 DOI: 10.1016/J.Conb.2011.08.002  0.31
2011 Cudaback E, Li X, Montine KS, Montine TJ, Keene CD. Apolipoprotein E isoform-dependent microglia migration. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 2082-91. PMID 21385991 DOI: 10.1096/Fj.10-176891  0.368
2011 Li X, Cudaback E, Keene CD, Breyer RM, Montine TJ. Suppressed microglial E prostanoid receptor 1 signaling selectively reduces tumor necrosis factor alpha and interleukin 6 secretion from toll-like receptor 3 activation. Glia. 59: 569-76. PMID 21319223 DOI: 10.1002/Glia.21125  0.43
2010 Cudaback E, Marrs W, Moeller T, Stella N. The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. Plos One. 5: e8702. PMID 20090845 DOI: 10.1371/Journal.Pone.0008702  0.575
2009 Sexton M, Woodruff G, Cudaback E, Kreitzer FR, Xu C, Lin YH, Möller T, Bai M, Manning HC, Bornhop D, Stella N. Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO. Plos One. 4: e8271. PMID 20020060 DOI: 10.1371/Journal.Pone.0008271  0.544
2007 Cudaback E, Stella N. Targeting astrocytomas and invading immune cells with cannabinoids: a promising therapeutic avenue. Molecular Neurobiology. 36: 36-44. PMID 17952648 DOI: 10.1007/S12035-007-0016-Z  0.524
2007 Muccioli GG, Xu C, Odah E, Cudaback E, Cisneros JA, Lambert DM, López Rodríguez ML, Bajjalieh S, Stella N. Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 2883-9. PMID 17360910 DOI: 10.1523/Jneurosci.4830-06.2007  0.57
2006 Witting A, Chen L, Cudaback E, Straiker A, Walter L, Rickman B, Möller T, Brosnan C, Stella N. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proceedings of the National Academy of Sciences of the United States of America. 103: 6362-7. PMID 16571660 DOI: 10.1073/Pnas.0510418103  0.66
Show low-probability matches.